Agilent Technologies, Inc.
HealthcareNYSE:A · New York Stock Exchange
-$0.05 today
Vol 0.56M · Avg 2.22M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$7.2B of revenue converted into $1.4B of net income for the selected period. Gross margin is 53.0% and net margin is 19.5%, showing how much revenue survives after costs and taxes. EPS is $4.98, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.9B +6.7% | $6.5B -4.7% | $6.8B -0.2% | $6.8B +8.4% | $6.3B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $3.3B +11.1% | $3.0B -11.7% | $3.4B +7.7% | $3.1B +7.3% | $2.9B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $3.6B +3.1% | $3.5B +2.0% | $3.5B -6.9% | $3.7B +9.2% | $3.4B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 52.4% -1.9pp | 54.3% +3.6pp | 50.7% -3.6pp | 54.4% +0.4pp | 53.9% | 9.8% | 28.9% | 38.3% |
| Research & Development | $455.0M -5.0% | $479.0M -0.4% | $481.0M +3.0% | $467.0M +5.9% | $441.0M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $1.7B +12.6% | $1.5B -7.1% | $1.6B -0.2% | $1.6B +1.1% | $1.6B | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $2.2B +5.7% | $2.0B -3.2% | $2.1B +0.5% | $2.1B +2.1% | $2.1B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $288.0M +12.1% | $257.0M -5.2% | $271.0M -14.5% | $317.0M -1.2% | $321.0M | $374.2M | $1.2B | $631.8M |
| EBITDA | $1.8B -2.1% | $1.9B +10.0% | $1.7B -10.6% | $1.9B +8.1% | $1.8B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 26.4% -2.4pp | 28.8% +3.9pp | 24.9% -2.9pp | 27.8% -0.1pp | 27.9% | 5.6% | 46.3% | 42.0% |
| Operating Income | $1.5B -0.6% | $1.5B +10.2% | $1.4B -16.6% | $1.6B +20.1% | $1.3B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 21.3% -1.6pp | 22.9% +3.1pp | 19.8% -3.9pp | 23.6% +2.3pp | 21.3% | 16.6% | 24.1% | 22.0% |
| Interest Income | $62.0M -22.5% | $80.0M +56.9% | $51.0M +466.7% | $9.0M +350.0% | $2.0M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $112.0M +16.7% | $96.0M +1.1% | $95.0M +13.1% | $84.0M +3.7% | $81.0M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$44.0M -233.3% | $33.0M +400.0% | -$11.0M +90.4% | -$114.0M -976.9% | $13.0M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $1.4B -5.7% | $1.5B +13.6% | $1.3B -11.0% | $1.5B +10.6% | $1.4B | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 20.7% -2.7pp | 23.4% +3.8pp | 19.6% -2.4pp | 22.0% +0.4pp | 21.5% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $132.0M -43.1% | $232.0M +134.3% | $99.0M -60.4% | $250.0M +66.7% | $150.0M | $1.3B | -$1.6B | $745.2M |
| Net Income | $1.3B +1.1% | $1.3B +4.0% | $1.2B -1.1% | $1.3B +3.6% | $1.2B | $4.9B | $4.8B | $4.7B |
| Net Margin | 18.8% -1.0pp | 19.8% +1.7pp | 18.1% -0.2pp | 18.3% -0.8pp | 19.1% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $5 +3.4% | $4 +5.2% | $4 +0.7% | $4 +5.3% | $4 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $5 +3.2% | $4 +5.7% | $4 +0.2% | $4 +6.1% | $4 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $283.0M -2.4% | $290.0M -1.4% | $294.0M -1.7% | $299.0M -1.6% | $304.0M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $284.0M -2.4% | $291.0M -1.7% | $296.0M -1.3% | $300.0M -2.3% | $307.0M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Becton, Dickinson and Company
NYSE:BDX
$52.80B
Cardinal Health, Inc.
NYSE:CAH
$52.28B
Edwards Lifesciences Corporation
NYSE:EW
$48.80B
Haleon plc
NYSE:HLN
$40.32B
Alcon Inc.
NYSE:ALC
$32.49B
IQVIA Holdings Inc.
NYSE:IQV
$29.87B
ResMed Inc.
NYSE:RMD
$28.03B
Waters Corporation
NYSE:WAT
$23.20B
Mettler-Toledo International Inc.
NYSE:MTD
$22.83B
Insmed Incorporated
NASDAQ:INSM
$21.19B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does A generate?
Agilent Technologies, Inc. (A) reported $6.95B of revenue in fiscal 2025.
Is A profitable?
Agilent Technologies, Inc. (A) reported $1.30B of net income, with a net margin of 18.8%.
Explore More
Continue the stock analysis
Jump to another research area for this company.